The global GLP-1 Receptor Agonist Market was valued at USD 66.4 billion in 2025 and is projected to grow from USD 82.0 billion in 2026 to USD 185.3 billion by 2033, registering a CAGR of 12.4% from 2026 to 2033. The market is witnessing remarkable growth due to the rising prevalence of type 2 diabetes, obesity, and other metabolic disorders, coupled with increasing clinical acceptance...